Biotech Exec Charged With COVID Test Fraud
The SEC says Arrayit President Mark Schena falsely claimed the company had developed a test and it was awaiting emergency FDA approval.
Illumina Buys Cancer Test Startup Grail for $8B
The deal will move Illumina “deeper into the application of its gene-sequencing technology to the diagnosis and treatment of patients."
Alexion Fined $21M in Foreign Corruption Probe
The SEC says the biotech firm made improper payments to Turkish and Russian officials to secure favorable treatment for its main drug.
Moderna Stock Soars on COVID Vaccine Results
Interim data from a Phase 1 study showed Moderna's vaccine candidate stimulated an immune response against the virus in people.
SEC Questions COVID Drug Claims of Biotechs
The commission has halted trading in the shares of three companies that have said they are developing a drug candidate for treating COVID-19.
Moderna Gets $483M to Fund Corona Vaccine
The grant from the U.S. government will boost Moderna's efforts to develop what is “among the most advanced coronavirus vaccine candidates.”
Four Pillars of Successful Corporate Decision-Making
Here's how to shift the decision-making process from a misunderstood art toward a mainstream science.
SEC Charges Former MiMedx Execs With Fraud
The C-suite executives allegedly improperly recognized revenue from distributors with which MiMedx had secret side arrangements.
Gilead to Invest $5B in Galapagos Partnership
The deal expands Gilead's investment in the European biotech as it seeks to add assets to its drug portfolio.
Insys Shares Dive on ‘Going Concern’ Doubts
The opioid seller's auditor expressed "substantial doubt" about its ability to continue as a going concern.
Biotech’s Moderna Poised for Market Debut
The startup's IPO would raise capital for "a new category of transformative medicines based on messenger RNA."